Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.

Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. Abstract Text:

Punniyakoti T Veeraveedu,Kenichi Watanabe,Meilei Ma,Suresh S Palaniyandi,Ken'ichi Yamaguchi,Makoto Kodama,Yoshifusa Aizawa,

Diuretics are frequently required to treat fluid retention in patients with chronic heart failure (CHF). Unfortunately, they can lead to a decline in renal function, electrolyte depletion, and neurohormonal activation. Arginine vasopressin (AVP) promotes renal water reabsorption via the V(2) receptor (V(2)R) and its levels are increased in CHF. This study was conducted to characterize the diuretic effect of tolvaptan, a non-peptide AVP V(2)R antagonist, and furosemide, a loop diuretic in a rat model of CHF after experimental autoimmune myocarditis. CHF was elicited in Lewis rats by immunization with porcine cardiac myosin, and 28 days after immunization rats were treated for 28 days with oral tolvaptan, and furosemide. CHF was characterized by left ventricular remodeling and impaired systolic and diastolic function. Tolvaptan produces a diuresis comparable to furosemide. Unlike tolvaptan, furosemide significantly increased urinary sodium and potassium excretion. Tolvaptan markedly elevated electrolyte-free water clearance (E-CH(2)O) or aquaresis to a positive value and increased urinary AVP excretion. In contrast to tolvaptan, furosemide elevated only electrolyte clearance (E-Cosm) but not E-CH(2)O. The differences in diuretic profile reflected the changes in plasma sodium and hormone levels. Tolvaptan dose dependently elevated plasma sodium concentration, but furosemide tended to decrease it. Furosemide significantly elevated plasma renin activity and aldosterone concentration. On the other hand, tolvaptan did not affect these parameters. Our results suggest that, tolvaptan have a potential medical benefit for the treatment of edematous conditions in CHF by removing excess water from the body without activating the RAAS or causing serum electrolyte imbalances.

Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. Publishing Authors By Initials

PT Veeraveedu,K Watanabe,M Ma,SS Palaniyandi,K Yamaguchi,M Kodama,Y Aizawa,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Biochemical pharmacology

VOLUME: 75

Page Numbers: 1322-30

Journal Abbreviation: Biochem. Pharmacol.

ISSN: 0006-2952

DAY: 3

MONTH: 12

YEAR: 2007

Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101032

Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.

AFFILIATION: Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 265-1 Higashijima Akiha-ku, Niigata City, Niigata 956-8603, Japan.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Biochem Pharmacol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure Related Publications

• Angiotensin type 1 receptor blockade prevents endocardial dysfunction of rapidly paced atria in rats.
• Characterization of smooth muscle components in renal angiomyolipomas: Histological and immunohistochemical comparison with renal capsular leiomyomas.
• Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats.
• Comparison of conduction delay in the right ventricular outflow tract between Brugada syndrome and right ventricular cardiomyopathy: investigation of signal average ECG in the precordial leads.
• Effect of dl-sotalol on mortality and recurrence of ventricular tachyarrhythmias: ischemic compared to nonischemic cardiomyopathy.
• Effects of nonpeptide vasopressin V2 antagonist tolvaptan in rats with heart failure.
• Effects of supplemental O2 inhalation on cerebral oxygenation during exercise in patients with left ventricular dysfunction.
• Effort-reward imbalance and social support are associated with chronic fatigue among medical residents in Japan.
• Evaluating patients with acute ischemic stroke with special reference to newly developed atrial fibrillation in cerebral embolism.
• Factors associated with workers' perceived helpfulness of and need for health consultations given by an occupational physician at a Japanese manufacturing plant.
• FliK regulates flagellar hook length as an internal ruler.
• Functional roles of the hook in a rotating tethered cell.
• Gabapentin for painful legs and moving toes syndrome.
• Impact of Nasal Condition on Self-assessed Disease Control and Treatment Satisfaction in Patients with Asthma Complicated by Allergic Rhinitis.
• Longitudinal change in renal function in patients with idiopathic dilated cardiomyopathy without renal insufficiency at initial diagnosis.
• Non-pharmacological management of ventricular tachycardia.
• Osteogenesis coordinated in C3H10T1/2 cells by adipogenesis-dependent BMP-2 expression system.
• Preheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents.
• Prevalence of airflow limitation on medical check-up in Japanese subjects.
• Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13.
• Recurrent thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus.
• Relationship between insulin-like growth factor-I and brain natriuretic Peptide in patients with acromegaly after surgery.
• Risk factors for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: retrospective analysis of 73 patients who received cyclosporin A.
• Spectral analysis and an area-preserving extension of a piecewise linear intermittent map.
• Successful all-trans retinoic acid treatment of acute promyelocytic leukemia in a patient with NPM/RAR fusion.
• Successful treatment of adult T-cell leukemia with unrelated cord blood transplantation.
• Temperature-hypersensitive sites of the flagellar switch component FliG in Salmonella enterica serovar typhimurium.
• [Pericardial abscess]
• [Prognostic factors of critical limb ischemia after autologous bone marrow implantation]
• [Review of 'sick house syndrome']